Suppr超能文献

微菌素 H47:一种 IIb 类微菌素,对多药耐药性具有强大的活性。

Microcin H47: A Class IIb Microcin with Potent Activity Against Multidrug Resistant .

机构信息

Department of Bioengineering, University of Massachusetts Dartmouth, 285 Old Westport Road, N. Dartmouth, Massachusetts 02747-2300, United States.

Department of Biology, University of Massachusetts Dartmouth, 285 Old Westport Road, N. Dartmouth, Massachusetts 02747-2300, United States.

出版信息

ACS Infect Dis. 2020 Apr 10;6(4):672-679. doi: 10.1021/acsinfecdis.9b00302. Epub 2020 Mar 2.

Abstract

Microcin H47 (MccH47) is an antimicrobial peptide produced by some strains of that has demonstrated inhibitory activity against enteric pathogens and has been heterologously overexpressed in proof-of-concept engineered probiotic applications. While most studies clearly demonstrate inhibitory activity against isolates, there are conflicting results on the qualitative capacity for MccH47 to inhibit strains of . Here, we rectify these inconsistencies via the overexpression and purification of a form of MccH47, termed MccH47-monoglycosylated enterobactin (MccH47-MGE). We then use purified MccH47 to estimate minimum inhibitory concentrations (MICs) against a number of medically relevant , including and numerous multidrug resistant (MDR) strains. While previous reports suggested that the spectrum of activity for MccH47 is quite narrow and restricted to activity against , our data demonstrate that MccH47 has broad and potent activity within the family, suggesting it as a candidate for further development toward treating MDR enteric infections.

摘要

微菌素 H47(MccH47)是一种由某些 产生的抗菌肽,对肠道病原体具有抑制活性,并已在概念验证工程益生菌应用中异源过表达。虽然大多数研究清楚地表明对 分离株具有抑制活性,但关于 MccH47 定性抑制 菌株的能力存在矛盾的结果。在这里,我们通过过表达和纯化一种形式的 MccH47,称为 MccH47-单糖基化肠菌素(MccH47-MGE),纠正了这些不一致。然后,我们使用纯化的 MccH47 来估计对许多与医学相关的 ,包括 和许多多药耐药(MDR)菌株的最小抑菌浓度(MIC)。虽然之前的报告表明 MccH47 的活性谱相当狭窄,仅限于对 的活性,但我们的数据表明 MccH47 在 家族中具有广泛而强大的活性,表明它是治疗 MDR 肠道感染的进一步开发的候选者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验